Photo Credit: Satyakam Banerjee/VCCircle

True North makes partial exit from drug research firm with strong gains

18 May, 2017

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.


Leave Your Comment
Exclusive: IVFA earns above-average return on partial exit from healthcare firm

Exclusive: IVFA earns above-average return on partial exit from healthcare firm

Joseph Rai 6 months ago
Private equity firm India Value Fund Advisors (IVFA), which raised a new fund last year and has been simultaneously looking to exit investments from its...
Exclusive: PE firm IVFA clocks decent returns from first partial exit this year

Exclusive: PE firm IVFA clocks decent returns from first partial exit this year

Joseph Rai 7 months ago
Private equity firm India Value Fund Advisors (IVFA) has marked first partial exit from its portfolio firms this year marking an unusually quick churn, albeit...
IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

Anuradha Verma 2 years ago
Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the stock exchanges, listing at a...
No Comments

True North makes partial exit from drug research firm with strong gains

Powered by WordPress.com VIP